TAKE Limited delivered strong Q1 FY27 results: consolidated revenue hit ₹30.37 Cr and net profit reached ₹1.06 Cr, reversing prior-year losses.

TS

Take Solutions LimitedFiled with the exchange

The company is strategically expanding into Biohacking, Nutraceuticals, and Digital Longevity Solutions, targeting high-margin, recurring revenue.

No comments yet. Be the first.

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.